ArticleApplied biochemistry and biotechnology2026
Plasticization of an Ageratum Conyzoides Natural Extract in Crosslinked Hydrogel: a Promising Material for Combating Wound Infection.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of advanced wound dressings that combine structural stability with therapeutic functionality is vital for improving the wound healing process. In this study, a polyvinyl alcohol (PVA) hydrogel crosslinked with citric acid (CA) was fabricated and loaded with phytochemicals extracted from Ageratum conyzoides (ACE-CA/PVA). The biodegradable, biocompatible hydrogel was fabricated via esterification and systematically analysed to confirm successful crosslinking, structural integrity, surface morphology, and thermal behaviour. The ACE-CA/PVA hydrogel exhibited pH-responsive swelling, favourable water retention, and a biphasic drug release profile. Antimicrobial studies demonstrated enhanced inhibition of Staphylococcus aureus, Escherichia coli, and Aspergillus niger compared to blank hydrogels, while cytotoxicity assays confirmed good biocompatibility with L929 fibroblast cells. Thermal analyses indicated improved char yield and flexibility, while morphological evaluation revealed hierarchical porosity conducive to controlled release and tissue integration. Collectively, the results highlight ACE-CA/PVA hydrogel as a promising dual-function wound dressing that provides both a moist healing environment and plant-derived bioactive therapeutic benefits. This work signifies the potential of integrating phytochemicals with polymeric hydrogels for next-generation clinical application in acute and chronic wound management.
Indexed as
Identifiers
41609908What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.